Evidence map›Paper›PMID 33790912›Full record

ArticleFrontiers in immunology2021

Development of an Inflammatory CD14

Ryutaro Iwabuchi, Keigo Ide, Kazutaka Terahara, Ryota Wagatsuma, Rieko Iwaki, Hiroko Matsunaga, Yasuko Tsunetsugu-Yokota, Haruko Takeyama, Yoshimasa Takahashi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Ryutaro IwabuchiDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Keigo IdeDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.
Kazutaka TeraharaDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Ryota WagatsumaDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.
Rieko IwakiDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Hiroko MatsunagaResearch Organization for Nano and Life Innovation, Waseda University, Tokyo, Japan.
Yasuko Tsunetsugu-YokotaDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Haruko TakeyamaDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.
Yoshimasa TakahashiDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
National Institute of Infectious Diseases · JPWaseda University · JPNational Institute of Advanced Industrial Science and Technology · JPTokyo University of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Humanized mouse models are attractive experimental models for analyzing the development and functions of human dendritic cells (DCs)

Indexed as

AnimalsAntigens, CD1CD4-Positive T-LymphocytesDendritic CellsGene Expression ProfilingGlycoproteinsHumansInflammation MediatorsLipopolysaccharide ReceptorsMiceAntigens, CD1CD1C protein, humanGlycoproteinsInflammation MediatorsLipopolysaccharide ReceptorsCD14DC3dendritic cellhumanized miceinflammatory responseS100A8S100A9

Identifiers

PMID33790912
PMCPMC8005643
OpenAlexW3139190700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.